MiNK Therapeutics Inc

XNAS:INKT  
12.20
0.00 (0.00%)
7:51:30 PM EDT: $12.29 +0.09 (+0.71%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

MiNK Therapeutics Inc Stock, XNAS:INKT

149 5th Avenue, Suite 500, New York, New York 10010
United States of America
Phone: +1.212.994.8250
Number of Employees: 23
http://www.minktherapeutics.com

Description

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.